HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Schirrmann Selected Research

Thomas Schirrmann Research Topics

Disease

13Neoplasms (Cancer)
01/2021 - 04/2002
3Infections
11/2021 - 01/2011
3Lymphoma (Lymphomas)
04/2014 - 04/2008
2Communicable Diseases (Infectious Diseases)
01/2021 - 02/2009
2Autoimmune Diseases (Autoimmune Disease)
01/2021 - 10/2016
2COVID-19
01/2021 - 01/2021
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
04/2014 - 01/2012
2Inflammation (Inflammations)
01/2013 - 01/2012
1Tetanus
01/2021
1Diphtheria
01/2021
1Chronic Disease (Chronic Diseases)
10/2016
1Adenocarcinoma
09/2016
1Pathologic Processes
01/2016
1Confusion (Bewilderment)
01/2016
1Human Influenza (Influenza)
11/2015
1Hodgkin Disease (Hodgkin's Disease)
04/2014
1Hematologic Neoplasms (Hematological Malignancy)
04/2014
1Paralysis (Palsy)
03/2014
1Bacterial Infections (Bacterial Infection)
01/2013
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2012
1Neuroblastoma
01/2012
1Carcinoma (Carcinomatosis)
01/2011
1Pneumonia (Pneumonitis)
09/2008
1Myeloid Leukemia (Leukemia, Myelocytic)
03/2005

Drug/Important Bio-Agent (IBA)

12AntibodiesIBA
01/2021 - 01/2009
6Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2008
3Neutralizing AntibodiesIBA
11/2021 - 05/2014
3Immunoglobulin G (IgG)IBA
01/2021 - 01/2011
3Monoclonal AntibodiesIBA
10/2016 - 01/2012
3Immunoglobulins (Immunoglobulin)IBA
03/2014 - 04/2002
2Pancreatic Ribonuclease (Ribonuclease A)IBA
01/2018 - 03/2014
2AntigensIBA
01/2018 - 03/2014
2Ribonucleases (Ribonuclease)IBA
01/2018 - 04/2008
2Peptides (Polypeptides)IBA
01/2012 - 09/2008
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
03/2005 - 04/2002
1Immunoglobulin FragmentsIBA
01/2021
1Recombinant DNA (Recombinant DNA Research)IBA
10/2016
1Cyclin-Dependent Kinase 4IBA
01/2016
1Pharmaceutical PreparationsIBA
01/2016
1Inosine Monophosphate (IMP)IBA
11/2015
1HLA-A*02:01 antigenIBA
11/2015
1Immunotoxins (Immunotoxin)IBA
04/2014
1Brentuximab VedotinIBA
04/2014
1Immunoconjugates (Immunoconjugate)IBA
04/2014
1incobotulinumtoxinAFDA Link
03/2014
1Biomarkers (Surrogate Marker)IBA
01/2013
1C-Reactive ProteinIBA
01/2013
1Ki-1 AntigenIBA
01/2012
1Neoplasm AntibodiesIBA
01/2010
1scleroglucanIBA
02/2009
1Carcinoembryonic AntigenIBA
04/2002

Therapy/Procedure

6Therapeutics
01/2021 - 01/2010
4Immunotherapy
01/2015 - 04/2002
2Drug Therapy (Chemotherapy)
04/2014 - 01/2012
1Radiotherapy
04/2014
1Lasers (Laser)
01/2012